enGene Holdings Inc. (ENGN) vs Insight Molecular Diagnostics Inc. (IMDX)
A side-by-side comparison of enGene Holdings Inc. and Insight Molecular Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENGN
enGene Holdings Inc.
$1.81HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
IMDX
Insight Molecular Diagnostics Inc.
$3.63HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — ENGN vs IMDX
growth of $100 · dividends reinvested · last 3yENGN -90.7% (-54.6%/yr)IMDX +57.2% (+16.3%/yr)IMDX compounded faster over this window
Log scale — wide-divergence pair
ENGN IMDX
ENGN vs IMDX: by the numbers
- •ENGN is the larger company ($121M vs $117M market cap).
- •Both run net losses; ENGN's is the smaller (0.00% vs -2955.63% net margin).
Metrics side by side
Valuation
| Metric | ENGN | IMDX |
|---|---|---|
| P/S ratio | N/A | 70.19 |
| P/B ratio | 0.53 | N/A |
Profitability
| Metric | ENGN | IMDX |
|---|---|---|
| Gross margin | 0.00% | 11.17% |
| Operating margin | 0.00% | -754.08% |
| Net margin | 0.00% | -2955.63% |
| ROE | -2.13% | N/A |
| ROIC | -1.78% | -223.06% |
Growth (annualized)
| Metric | ENGN | IMDX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 27.24% |
| Total return CAGR (5Y) | N/A | -44.39% |
Go deeper
Dig into the metrics
enGene ROEInsight Molecular Diagnostics ROEenGene operating marginInsight Molecular Diagnostics operating marginenGene revenue growthInsight Molecular Diagnostics revenue growthenGene free cash flowInsight Molecular Diagnostics free cash flow
enGene & Insight Molecular Diagnostics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.